// PROTOCOLS / longevity
▶ Longevity protocol
Longevity pages distinguish between measured healthspan practices, biomarker claims, public critiques, and low-confidence aspirational claims such as immortality by 2039.
Daily inputs, long-range targets, and explicit avoidances are separated into the same terminal panels as the BJ.WATCH reference. Source-aware summary only.
idxtimehabit
01 nightHBT Prioritize measured healthspan basics: exercise, sleep regularity, nutrition, risk-factor monitoring, and clinician-guided prevention.
concepts/immortality-by-2039.md 02 dailyHBT Read biological-age and speed-of-aging numbers as tracked claims with source trails and critique links nearby.
concepts/biomarker-driven-longevity-protocols.md Long-term objectives
target 01 Separate durable healthspan practices from frontier enhancement, drug-stack, gene-therapy, and immortality narratives.concepts/immortality-by-2039.md
target 02 Classify daily Tadalafil/Cialis and similar drug claims as hypothesis-generating prescription-intervention claims unless independent clinical evidence supports the exact longevity use case.concepts/biomarker-driven-longevity-protocols.md
target 03 do not treat off-label longevity positioning as proven outcome evidence.concepts/blueprint-protocol.md
target 04 Classify sauna/HSP27 claims as mechanistic biomarker self-experimentation unless replicated and tied to clinically meaningful outcomes.raw/articles/blueprint-immortal-by-2039-2026-01-30.md
target 05 structural imaging may complement chemical and functional data, but the third-party device and routine-screening claims need validation.raw/articles/bryan-johnson/years-biomarkers-limits-2026-04-20.md
target 06 consistency can help trend detection, but it does not settle absolute accuracy or clinical validity.raw/articles/bryan-johnson/mdlinx-blueprint-critique-2025-02-15.md
target 07 useful for understanding Johnson’s measurement stack, not evidence that broad genetic screening improves outcomes for every reader.raw/articles/bryan-johnson/x-twitter-daily-2026-06-13.md
target 08 Classify the July 2026 single-cell immune sequencing thread as an AIG diagnostic/readout extension, not as proof that Johnson has a validated antigen-specific therapy.raw/articles/bryan-johnson/x-twitter-daily-2026-06-17.md
target 09 it does not increase confidence in the 2039 forecast.raw/articles/bryan-johnson/x-twitter-daily-2026-06-20.md
target 10 Keep the June 2026 immortality manifesto and “Die Economy” frame in the ideology/forecast lane unless independent evidence supports the specific biological and AI claims.raw/articles/bryan-johnson/x-twitter-daily-2026-06-23.md
target 11 Keep critiques visible so biomarker improvements do not become unsupported longevity promises.raw/articles/bryan-johnson/x-twitter-daily-2026-06-24.md
Forbidden
FORBID: Do not render “immortality by 2039” as a realistic forecast or medical endpoint.
FORBID: Do not collapse Johnson’s ideology, Blueprint marketing, and independent evidence into one confidence level.